Search research articles
Contact Us
Filters
Showing results (151-160 of 171) with videos related to
Page
of 18
Sort By:
The Annals of Thoracic Surgery
|
December 1, 1992
Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study
D M Cosgrove, B Heric, B W Lytle, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
June 1, 1987
Fifteen hundred coronary reoperations. Results and determinants of early and late survival
B W Lytle, F D Loop, D M Cosgrove, et al.
The Annals of Thoracic Surgery
|
February 1, 1990
J. Maxwell Chamberlain memorial paper. Sternal wound complications after isolated coronary artery bypass grafting: early and late mortality, morbidity, and cost of care
F D Loop, B W Lytle, D M Cosgrove, et al.
The Annals of Thoracic Surgery
|
December 5, 1997
Third coronary artery bypass operations: risks and costs
B W Lytle, J L Navia, P C Taylor, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
January 1, 1996
Surgical treatment of prosthetic valve endocarditis
B W Lytle, B P Priest, P C Taylor, et al.
Circulation
|
September 1, 1986
Results of mitral valve reconstruction
D M Cosgrove, A M Chavez, B W Lytle, et al.
Annals of the Rheumatic Diseases
|
December 21, 2016
Filgotinib (GLPG0634/GS-6034), an oral JAK1 selective inhibitor, is effective in combination with methotrexate (MTX) in patients with active rheumatoid arthritis and insufficient response to MTX: results from a randomised, dose-finding study (DARWIN 1)
R Westhovens, P C Taylor, R Alten, et al.
The Annals of Thoracic Surgery
|
December 1, 1992
Postcardiotomy centrifugal mechanical ventricular support
L A Golding, R D Crouch, R W Stewart, et al.
The Annals of Thoracic Surgery
|
November 1, 1994
Coronary reoperation: results of adding an internal mammary artery graft to a stenotic vein graft
F E Turner, B W Lytle, D Navia, et al.
Arthritis and Rheumatism
|
September 2, 2006
Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate
R N Maini, P C Taylor, J Szechinski, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 171) with videos related to
Sort By:
Page
of 18
The Annals of Thoracic Surgery
|
December 1, 1992
Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study
D M Cosgrove, B Heric, B W Lytle, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
June 1, 1987
Fifteen hundred coronary reoperations. Results and determinants of early and late survival
B W Lytle, F D Loop, D M Cosgrove, et al.
The Annals of Thoracic Surgery
|
February 1, 1990
J. Maxwell Chamberlain memorial paper. Sternal wound complications after isolated coronary artery bypass grafting: early and late mortality, morbidity, and cost of care
F D Loop, B W Lytle, D M Cosgrove, et al.
The Annals of Thoracic Surgery
|
December 5, 1997
Third coronary artery bypass operations: risks and costs
B W Lytle, J L Navia, P C Taylor, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
January 1, 1996
Surgical treatment of prosthetic valve endocarditis
B W Lytle, B P Priest, P C Taylor, et al.
Circulation
|
September 1, 1986
Results of mitral valve reconstruction
D M Cosgrove, A M Chavez, B W Lytle, et al.
Annals of the Rheumatic Diseases
|
December 21, 2016
Filgotinib (GLPG0634/GS-6034), an oral JAK1 selective inhibitor, is effective in combination with methotrexate (MTX) in patients with active rheumatoid arthritis and insufficient response to MTX: results from a randomised, dose-finding study (DARWIN 1)
R Westhovens, P C Taylor, R Alten, et al.
The Annals of Thoracic Surgery
|
December 1, 1992
Postcardiotomy centrifugal mechanical ventricular support
L A Golding, R D Crouch, R W Stewart, et al.
The Annals of Thoracic Surgery
|
November 1, 1994
Coronary reoperation: results of adding an internal mammary artery graft to a stenotic vein graft
F E Turner, B W Lytle, D Navia, et al.
Arthritis and Rheumatism
|
September 2, 2006
Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate
R N Maini, P C Taylor, J Szechinski, et al.
Page
of 18